Treglia Giorgio, Castaldi Paola, Villani Maria Felicia, Perotti Germano, Filice Angelina, Ambrosini Valentina, Cremonini Nadia, Versari Annibale, Fanti Stefano, Giordano Alessandro, Rufini Vittoria
Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Rome, Italy.
Recent Results Cancer Res. 2013;194:385-93. doi: 10.1007/978-3-642-27994-2_21.
Several morphological and functional imaging techniques are usually used to detect residual/recurrent medullary thyroid carcinoma (MTC) with variable results; currently, there is growing interest in positron emission tomography (PET) methodology. Herein, we report our experience of and a literature review about the comparison of different positron emission tomography (PET) tracers in patients with residual/recurrent MTC. (18)F-DOPA PET/CT seems to be the most useful imaging method to detect recurrent MTC lesions, performing better than (18)F-FDG and (68)Ga-somatostatin analogs PET/CT. (18)F-FDG may complement (18)F-DOPA in patients with aggressive tumors. (68)Ga-somatostatin analogs PET/CT may be useful to select patients who could benefit from radioreceptor therapy. The information provided by the various PET tracers reflects different metabolic pathways, and may help to select the most appropriate treatment.
几种形态学和功能成像技术通常用于检测残余/复发性甲状腺髓样癌(MTC),结果各异;目前,正电子发射断层扫描(PET)方法越来越受到关注。在此,我们报告了我们在残余/复发性MTC患者中比较不同正电子发射断层扫描(PET)示踪剂的经验及文献综述。(18)F-DOPA PET/CT似乎是检测复发性MTC病变最有用的成像方法,其表现优于(18)F-FDG和(68)Ga-生长抑素类似物PET/CT。(18)F-FDG可在侵袭性肿瘤患者中补充(18)F-DOPA。(68)Ga-生长抑素类似物PET/CT可能有助于选择可从放射受体治疗中获益的患者。各种PET示踪剂提供的信息反映了不同的代谢途径,可能有助于选择最合适的治疗方法。